Diagnostic performance of magnetic resonance enterography disease activity indices compared with a histological reference standard for adult terminal ileal Crohn’s disease: experience from the METRIC trial

Diagnostic performance of magnetic resonance enterography disease activity indices compared with a histological reference standard for adult terminal ileal Crohn’s disease: experience from the METRIC trial

<p><strong>Background and Aims:</strong> The simplified magnetic resonance enterography [MRE] index of activity [sMARIA], London, and ‘extended’ London, scoring systems are widely used in Crohn’s disease [CD] to assess disease activity, although validation studies have usually been...

Descripció completa

Dades bibliogràfiques
Autors principals:	Kumar, S, Parry, T, Mallett, S, Bhatnagar, G, Plumb, A, Walsh, S, Scott, N, Tandon, R, Chong, H, du Parcq, J, Martinez, A, Moorghen, M, Rodriguez-Justo, M, Halligan, S, Taylor, SA, Travis, S
Altres autors:	METRIC study investigators
Format:	Journal article
Idioma:	English
Publicat:	Oxford University Press 2022
Matèries:	Imaging

Ítems similars

METRIC-EF: magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease—protocol for a multicentre, non-randomised, single-arm, prospective study
per: Kumar, S, et al.
Publicat: (2022)

Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trial
per: Taylor, SA, et al.
Publicat: (2018)

METRIC (MREnterography or ulTRasound in Crohn’s disease): a study protocol for a multicentre, non-randomised, single-arm, prospective comparison study of magnetic resonance enterography and small bowel ultrasound compared to a reference standard in those aged 16 and over
per: Taylor, S, et al.
Publicat: (2014)

Connective tissue changes in ileal Crohn's disease: relationship to disease phenotype and ulcer-associated cell lineage.
per: Borley, N, et al.
Publicat: (2001)

Crohn’s disease or Crohn’s diseases?
per: Arnott, IDR, et al.
Publicat: (2003)

Maintenance of Crohn's disease over 12 months: fixed versus flexible dosing regimen using budesonide controlled ileal release capsules.
per: Green, JR, et al.
Publicat: (2001)

Medical management of Crohn's disease.
per: Cummings, JR, et al.
Publicat: (2008)

Stress-related consequences of the coronavirus disease 2019 pandemic on symptoms of Crohn's disease
per: Goodday, SM, et al.
Publicat: (2021)

The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link.
per: Borley, N, et al.
Publicat: (2000)

Interfering with leukocyte trafficking in Crohn's disease
per: Biswas, S, et al.
Publicat: (2019)

Matrix metalloproteinases as profibrotic factors in terminal ileum in Crohn's disease.
per: Warnaar, N, et al.
Publicat: (2006)

Mortality in patients hospitalised with Crohn's disease.
per: Siffledeen, J, et al.
Publicat: (2012)

Is Crohn's disease a rightly used eponym?
per: Van Hootegem, P, et al.
Publicat: (2019)

Smoking status in therapeutic trials in Crohn's disease.
per: McGovern, D, et al.
Publicat: (2005)

Crohn's disease and pregnancy.
per: Khosla, R, et al.
Publicat: (1984)

Perianal Crohn's disease.
per: Singh, B, et al.
Publicat: (2004)

Review article: insurance risks for patients with ulcerative colitis or Crohn's disease.
per: Travis, S
Publicat: (1997)

Immunosuppression for management of Crohn's disease
per: Milosevic, I, et al.
Publicat: (2016)

Field Cancerization in Crohn's Disease
per: Graham, T, et al.
Publicat: (2010)

Evidence for separate disease phenotypes in intestinal Crohn's disease.
per: Borley, N, et al.
Publicat: (2002)

NOD2 function in Crohn's disease.
per: Simmons, A
Publicat: (2011)

Treatment of Crohn's disease--the new era.
per: Jewell, D
Publicat: (2002)

Prevention of postoperative recurrence of Crohn's disease.
per: van Loo, E, et al.
Publicat: (2012)

NOD2 SIGNALLING IN CROHN'S DISEASE
per: Allan, P, et al.
Publicat: (2011)

Yersinia colitis associated with Crohn's disease.
per: Treacher, D, et al.
Publicat: (1985)

Endocrine dysfunction in children with Crohn's disease.
per: Chong, S, et al.
Publicat: (1984)

Prevention of postoperative recurrence of Crohn's disease
per: Van Loo, E, et al.
Publicat: (2012)

Pathogenesis of Crohn's disease: the environment revisited.
per: Jewell, D
Publicat: (1995)

Crohn's disease: Genes, viruses and microbes.
per: Simmons, A
Publicat: (2010)

Preventing postoperative recurrence of Crohn's disease.
per: Borley, N, et al.
Publicat: (1997)

Comparison between prospective and retrospective evaluation of Crohn's disease activity index.
per: Frenz, M, et al.
Publicat: (2005)

Impact of interobserver disagreement on phenotype-genotype associations in Crohn's disease.
per: Oefferlbauer-Ernst, A, et al.
Publicat: (2007)

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.
per: D'Haens, G, et al.
Publicat: (2009)

Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: a critical systematic review.
per: Cassinotti, A, et al.
Publicat: (2009)

Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery.
per: Tzivanakis, A, et al.
Publicat: (2012)

Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
per: Hyder, SA, et al.
Publicat: (2006)

Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery.
per: Tzivanakis, A, et al.
Publicat: (2012)

Combining clinical risk factors and genotype to predict postoperative recurrence of Crohn's disease
per: Johns, E, et al.
Publicat: (2003)

Has primary sclerosing cholangitis associated with Crohn's disease a better outcome? Reply
per: Halliday, J, et al.
Publicat: (2012)

Sarcoidosis complicating treatment with natalizumab for Crohn's disease
per: Parisinos, C, et al.
Publicat: (2011)